Avinger Inc
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $7.7M | $8.3M | $10.1M | $8.8M | $9.1M | $7.9M |
| Operating income | −$16.6M | −$16.0M | −$18.1M | −$17.4M | −$19.4M | −$23.0M |
| Net income | −$18.3M | −$17.6M | −$17.4M | −$19.0M | −$19.4M | −$27.6M |
| Total assets | $13.8M | $24.2M | $29.5M | $33.2M | $23.8M | $23.7M |
| Total liabilities | $20.0M | $20.0M | $19.8M | $20.1M | $16.9M | $14.2M |
| Equity | −$6.2M | $4.1M | $9.7M | $13.1M | $6.9M | $9.5M |
| EPS (diluted) | $-23.31 | $-65.33 | $-4.57 | — | — | — |
| Shares out. | 8.6M | 5.4M | 95.3M | 16.8M | 42.3M | 4.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −217.4%
- Net margin
- −239.4%
- Return on equity
- 295.4%
- Return on assets
- −133.0%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 145.0%
- Debt / equity
- —
- Book value / share
- $-0.72
- Revenue growth (YoY)
- −7.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -111.44distress
- Accruals / assets
- −28.2%clean
- Beneish M-Score
- -4.11normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Bankruptcy or receivership · Completed an acquisition or disposition · Changed auditor · Director / officer change · Shareholder voteFeb 10, 2025
- Shareholder voteFeb 5, 2025
- Shareholder voteJan 24, 2025
- Other material eventJan 3, 2025
- Unregistered equity sale · Modified shareholder rights · Amended charter or bylaws · Shareholder voteJan 2, 2025
- Director / officer change · Shareholder voteDec 19, 2024
- Director / officer changeDec 13, 2024
- Debt acceleration / triggering event · Other material eventDec 11, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 25-NSEJun 23, 2025
- SCHEDULE 13G/AFeb 14, 2025
- 8-KFORM 8-KFeb 10, 2025
- 8-KFORM 8-KFeb 5, 2025
- 4FORM 4Jan 24, 2025
- 4FORM 4Jan 24, 2025
- 4FORM 4Jan 24, 2025
- DEFA14AFORM DEFA14AJan 24, 2025
- 8-KFORM 8-KJan 24, 2025
- 144Jan 23, 2025
- 144Jan 23, 2025
- 144Jan 23, 2025
- DEFR14AFORM DEFR14AJan 13, 2025
- DEFA14AFORM DEFA14AJan 13, 2025
- 8-KFORM 8-KJan 3, 2025